wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33410380-3C2F96AE-8485-4707-B406-A816E37592FD
Q33410380-3C2F96AE-8485-4707-B406-A816E37592FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33410380-3C2F96AE-8485-4707-B406-A816E37592FD
Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas
P2860
Q33410380-3C2F96AE-8485-4707-B406-A816E37592FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33410380-3C2F96AE-8485-4707-B406-A816E37592FD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d175a61f2880533c0acd167678edef701fcd6313
P2860
Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.